Anavex Historical Balance Sheet

AVXL Stock

USD 4.50 0.15 3.45%

Trend analysis of Anavex Life Sciences balance sheet accounts such as Other Current Liab of 8.8 M, Total Current Liabilities of 15.1 M or Total Stockholder Equity of 171.3 M provides information on Anavex Life's total assets, liabilities, and equity, which is the actual value of Anavex Life Sciences to its prevalent stockholders. By breaking down trends over time using Anavex Life balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Anavex Life Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Anavex Life Sciences is a good buy for the upcoming year.

Anavex Life Inventory

15,464.93

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.

About Anavex Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Anavex Life Sciences at a specified time, usually calculated after every quarter, six months, or one year. Anavex Life Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Anavex Life and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Anavex currently owns. An asset can also be divided into two categories, current and non-current.

Anavex Life Balance Sheet Chart

Anavex Life Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Anavex Life Sciences uses and utilizes its capital. It also shows what exactly a company owns and owes.

At this time, Anavex Life's Cash And Short Term Investments are quite stable compared to the past year. Common Stock Total Equity is expected to rise to about 94.1 K this year, although the value of Retained Earnings are projected to rise to (250.6 M).

Total Assets Other Current Liab Total Current Liabilities Cash And Short Term Investments Non Current Liabilities Total

Add Fundamental

Total Assets

Total assets refers to the total amount of Anavex Life assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Anavex Life Sciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Anavex Life balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Anavex Life Sciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Anavex Life Sciences balance sheet. This account contains Anavex Life investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Anavex Life Sciences fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Most accounts from Anavex Life's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Anavex Life Sciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	5.9M	7.3M	8.4M	8.8M
Total Assets	152.7M	154.4M	177.5M	186.4M

Other Current Liab Total Assets

Anavex Life balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Short Long Term Debt Total	Other Current Assets	Short Term Debt	Property Plant And Equipment Net	Current Deferred Revenue	Non Current Assets Total	Property Plant And Equipment Gross	Non Current Liabilities Total	Net Receivables	Net Tangible Assets	Other Assets
Total Assets		0.93	0.96	1.0	-0.98	-0.93	1.0	1.0	0.9	0.91	0.98	0.93	1.0	0.91	0.78	-0.22	0.05	-0.36	-0.08	0.58	-0.26	-0.08	0.85	0.64	1.0	0.32
Other Current Liab	0.93		0.95	0.93	-0.89	-0.91	0.93	0.93	0.9	0.92	0.95	0.9	0.93	0.91	0.81	-0.29	0.01	-0.27	-0.11	0.73	-0.07	-0.11	0.78	0.45	0.93	0.21
Total Current Liabilities	0.96	0.95		0.96	-0.93	-0.96	0.96	0.96	0.95	0.96	0.99	0.96	0.96	0.95	0.85	-0.28	0.14	-0.32	-0.11	0.69	-0.27	-0.11	0.85	0.63	0.96	0.22
Total Stockholder Equity	1.0	0.93	0.96		-0.98	-0.93	1.0	1.0	0.89	0.91	0.98	0.93	1.0	0.9	0.78	-0.24	0.04	-0.37	-0.09	0.56	-0.26	-0.09	0.84	0.64	1.0	0.33
Net Debt	-0.98	-0.89	-0.93	-0.98		0.93	-0.98	-0.98	-0.87	-0.88	-0.95	-0.89	-0.98	-0.87	-0.76	0.25	-0.04	0.36	0.11	-0.55	0.24	0.11	-0.79	-0.68	-0.98	-0.4
Retained Earnings	-0.93	-0.91	-0.96	-0.93	0.93		-0.93	-0.93	-0.94	-0.97	-0.97	-0.93	-0.93	-0.95	-0.87	0.25	-0.23	0.38	0.08	-0.71	0.22	0.08	-0.8	-0.61	-0.93	-0.33
Cash	1.0	0.93	0.96	1.0	-0.98	-0.93		1.0	0.9	0.91	0.98	0.93	1.0	0.91	0.78	-0.22	0.04	-0.35	-0.08	0.57	-0.26	-0.08	0.85	0.62	1.0	0.33
Cash And Short Term Investments	1.0	0.93	0.96	1.0	-0.98	-0.93	1.0		0.9	0.91	0.98	0.93	1.0	0.91	0.78	-0.22	0.04	-0.35	-0.08	0.57	-0.26	-0.08	0.85	0.62	1.0	0.33
Common Stock Total Equity	0.9	0.9	0.95	0.89	-0.87	-0.94	0.9	0.9		0.93	0.94	0.96	0.9	1.0	0.88	-0.08	0.21	-0.21	0.12	0.83	-0.21	0.12	0.86	0.62	0.89	0.26
Common Stock Shares Outstanding	0.91	0.92	0.96	0.91	-0.88	-0.97	0.91	0.91	0.93		0.96	0.9	0.91	0.94	0.93	-0.32	0.29	-0.48	-0.12	0.71	-0.08	-0.12	0.74	0.61	0.91	0.27
Other Stockholder Equity	0.98	0.95	0.99	0.98	-0.95	-0.97	0.98	0.98	0.94	0.96		0.96	0.98	0.95	0.84	-0.24	0.14	-0.37	-0.07	0.66	-0.25	-0.07	0.86	0.58	0.98	0.28
Total Liab	0.93	0.9	0.96	0.93	-0.89	-0.93	0.93	0.93	0.96	0.9	0.96		0.93	0.97	0.79	0.02	0.09	-0.22	0.1	0.71	-0.33	0.1	0.96	0.59	0.93	0.2
Total Current Assets	1.0	0.93	0.96	1.0	-0.98	-0.93	1.0	1.0	0.9	0.91	0.98	0.93		0.91	0.78	-0.22	0.05	-0.36	-0.08	0.58	-0.26	-0.08	0.85	0.64	1.0	0.32
Common Stock	0.91	0.91	0.95	0.9	-0.87	-0.95	0.91	0.91	1.0	0.94	0.95	0.97	0.91		0.87	-0.08	0.2	-0.21	0.11	0.82	-0.22	0.11	0.87	0.6	0.9	0.24
Accounts Payable	0.78	0.81	0.85	0.78	-0.76	-0.87	0.78	0.78	0.88	0.93	0.84	0.79	0.78	0.87		-0.32	0.32	-0.52	0.05	0.76	0.08	0.05	0.61	0.62	0.78	0.13
Short Long Term Debt Total	-0.22	-0.29	-0.28	-0.24	0.25	0.25	-0.22	-0.22	-0.08	-0.32	-0.24	0.02	-0.22	-0.08	-0.32		-0.17	0.37	0.59	-0.06	-0.13	0.59	0.21	-0.2	-0.24	-0.08
Other Current Assets	0.05	0.01	0.14	0.04	-0.04	-0.23	0.04	0.04	0.21	0.29	0.14	0.09	0.05	0.2	0.32	-0.17		-0.25	-0.09	0.29	0.02	-0.09	-0.01	0.15	0.04	-0.07
Short Term Debt	-0.36	-0.27	-0.32	-0.37	0.36	0.38	-0.35	-0.35	-0.21	-0.48	-0.37	-0.22	-0.36	-0.21	-0.52	0.37	-0.25		0.2	0.09	-0.18	0.2	-0.12	-0.28	-0.36	-0.1
Property Plant And Equipment Net	-0.08	-0.11	-0.11	-0.09	0.11	0.08	-0.08	-0.08	0.12	-0.12	-0.07	0.1	-0.08	0.11	0.05	0.59	-0.09	0.2		0.18	-0.07	1.0	0.19	-0.11	-0.09	-0.05
Current Deferred Revenue	0.58	0.73	0.69	0.56	-0.55	-0.71	0.57	0.57	0.83	0.71	0.66	0.71	0.58	0.82	0.76	-0.06	0.29	0.09	0.18		0.04	0.18	0.55	0.34	0.57	0.07
Non Current Assets Total	-0.26	-0.07	-0.27	-0.26	0.24	0.22	-0.26	-0.26	-0.21	-0.08	-0.25	-0.33	-0.26	-0.22	0.08	-0.13	0.02	-0.18	-0.07	0.04		-0.07	-0.47	-0.24	-0.25	-0.16
Property Plant And Equipment Gross	-0.08	-0.11	-0.11	-0.09	0.11	0.08	-0.08	-0.08	0.12	-0.12	-0.07	0.1	-0.08	0.11	0.05	0.59	-0.09	0.2	1.0	0.18	-0.07		0.19	-0.11	-0.09	-0.05
Non Current Liabilities Total	0.85	0.78	0.85	0.84	-0.79	-0.8	0.85	0.85	0.86	0.74	0.86	0.96	0.85	0.87	0.61	0.21	-0.01	-0.12	0.19	0.55	-0.47	0.19		0.52	0.84	0.1
Net Receivables	0.64	0.45	0.63	0.64	-0.68	-0.61	0.62	0.62	0.62	0.61	0.58	0.59	0.64	0.6	0.62	-0.2	0.15	-0.28	-0.11	0.34	-0.24	-0.11	0.52		0.64	0.14
Net Tangible Assets	1.0	0.93	0.96	1.0	-0.98	-0.93	1.0	1.0	0.89	0.91	0.98	0.93	1.0	0.9	0.78	-0.24	0.04	-0.36	-0.09	0.57	-0.25	-0.09	0.84	0.64		0.33
Other Assets	0.32	0.21	0.22	0.33	-0.4	-0.33	0.33	0.33	0.26	0.27	0.28	0.2	0.32	0.24	0.13	-0.08	-0.07	-0.1	-0.05	0.07	-0.16	-0.05	0.1	0.14	0.33

Click cells to compare fundamentals

Anavex Life Account Relationship Matchups

Anavex Life balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	34.5M	161.6M	152.7M	154.4M	177.5M	186.4M
Other Current Liab	3.3M	5.6M	5.9M	7.3M	8.4M	8.8M
Total Current Liabilities	7.3M	10.8M	10.2M	12.5M	14.4M	15.1M
Total Stockholder Equity	27.2M	150.8M	142.5M	141.9M	163.1M	171.3M
Net Debt	(29.2M)	(152.1M)	(149.2M)	(151.0M)	(135.9M)	(129.1M)
Retained Earnings	(159.7M)	(197.6M)	(245.6M)	(293.1M)	(263.8M)	(250.6M)
Cash	29.2M	152.1M	149.2M	151.0M	173.7M	182.4M
Cash And Short Term Investments	29.2M	152.1M	149.2M	151.0M	173.7M	182.4M
Common Stock Total Equity	52.7K	62.0K	75.9K	77.9K	89.6K	94.1K
Common Stock Shares Outstanding	58.2M	69.8M	76.9M	79.8M	91.8M	96.3M
Liabilities And Stockholders Equity	34.5M	161.6M	152.7M	154.4M	177.5M	186.4M
Other Stockholder Equity	186.9M	348.3M	388.0M	434.8M	500.1M	525.1M
Total Liab	7.3M	10.8M	10.2M	12.5M	14.4M	15.1M
Total Current Assets	34.5M	161.6M	152.7M	154.4M	177.5M	186.4M
Common Stock	62.0K	75.9K	77.9K	82K	94.3K	99.0K
Accounts Payable	4.0M	4.7M	3.8M	4.3M	5.0M	5.2M
Other Current Assets	443.8K	355.5K	354.2K	653K	751.0K	495.2K
Non Current Liabilities Total	3.3M	5.6M	4.3M	7.3M	8.4M	8.8M
Net Receivables	4.8M	9.1M	3.2M	2.7M	3.1M	2.1M
Net Tangible Assets	27.2M	150.8M	142.5M	141.9M	163.1M	171.3M
Retained Earnings Total Equity	(133.4M)	(159.7M)	(197.6M)	(245.6M)	(221.0M)	(210.0M)
Capital Surpluse	153.6M	186.9M	348.3M	388.0M	446.2M	468.5M
Net Invested Capital	27.2M	150.8M	142.5M	141.9M	163.1M	82.9M
Net Working Capital	27.2M	150.8M	142.5M	141.9M	163.1M	82.9M
Capital Stock	62.0K	75.9K	77.9K	82K	94.3K	72.7K

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Anavex Life Sciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

When determining whether Anavex Life Sciences is a strong investment it is important to analyze Anavex Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Anavex Life's future performance. For an informed investment choice regarding Anavex Stock, refer to the following important reports:

How To Invest In Anavex

Details

Is Anavex Stock a good investment?

Details

What is Anavex Life's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for Anavex Stock analysis

When running Anavex Life's price analysis, check to measure Anavex Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anavex Life is operating at the current time. Most of Anavex Life's value examination focuses on studying past and present price action to predict the probability of Anavex Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anavex Life's price. Additionally, you may evaluate how the addition of Anavex Life to your portfolios can decrease your overall portfolio volatility.

	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk

Is Anavex Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.49)

Return On Assets

(0.20)

Return On Equity

(0.29)

The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Anavex Historical Balance Sheet

Anavex Life Inventory

15,464.93

About Anavex Balance Sheet Analysis

Anavex Life Balance Sheet Chart

Total Assets

Total Current Liabilities

Cash And Short Term Investments

Anavex Life balance sheet Correlations

Anavex Life Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Anavex Life balance sheet Accounts

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Anavex Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Tangible Assets	+ 1.0	Total Assets
Cash	+ 1.0	Total Stockholder Equity

Net Tangible Assets	- 0.98	Net Debt
Total Current Assets	- 0.98	Net Debt
Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Net Debt	- 0.98	Total Stockholder Equity
Net Debt	- 0.98	Total Assets